Répertoire des subventions financées

Filtrer par

592 ésultat(s) trouvé(s)

Assessing the Efficacy of a Hypomethylating Agent to Decrease Post-Pneumonia Cognitive Impairments

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer Society Research Program (ASRP)

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $99,999

  • Contribution Santé Canada

    $49,999

Aperçu du projet

Infections like pneumonia can speed up dementia. Vaccinations can prevent infections but don’t always work in older adults. We need new drugs to keep aging brains healthy after infections. We found that after mice recover from pneumonia they experience something like dementia. When we gave them a drug called 5’-AZA…

Projet en cours

Voir le projet et les chercheurs

Boosting self-cueing to maintain independence in dementia

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer Society Research Program (ASRP)

  • Province

    Ontario

  • Date de Début

    2024

  • Montant total du financement

    $99,991

  • Contribution Santé Canada

    $51,026

Aperçu du projet

Everyday activities such as cooking often become difficult for people living with dementia. We have found that they can still do the physical bits, such as filling a kettle or peeling a potato. The problem is with the cognitive ‘glue’ that sticks the physical steps together. Research has shown that…

Projet en cours

Voir le projet et les chercheurs

The role of TMEM106B in Alzheimer’s disease pathophysiology

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer Society Research Program (ASRP)

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Alzheimer's disease is a common form of memory loss and confusion affecting older adults. Despite many years of study, we still don't have a cure for this disease. Researchers have found that certain genes might play a role, but we are still trying to understand how these genes actually cause…

Projet en cours

Voir le projet et les chercheurs

A critical examination of family caregivers’ views on and experiences with medical assistance in dying

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer Society Research Program (ASRP)

  • Province

    British Columbia

  • Date de Début

    2024

  • Montant total du financement

    $78,846

  • Contribution Santé Canada

    $39,423

Aperçu du projet

Individuals with an incurable condition marked by decline and intolerable suffering and where death is reasonably foreseeable, as with dementia, now have access to medical assistance in dying (MAID). Family caregivers ofpersons living with dementia support MAID but the reasons for this support are poorly understood. This study aims to…

Projet en cours

Voir le projet et les chercheurs

Establishing protein signatures of MRI-detected vascular brain injury in circulating endothelial-derived extracellularvesicles in Alzheimer’s disease

  • Type de subvention

    Capacity building grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Compétition

    Alzheimer Society Research Program (ASRP)

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $100,000

  • Contribution Santé Canada

    $50,000

Aperçu du projet

Age-related dementias are reaching epidemic levels, affecting over 600,000 Canadians. The most common cause of age-related dementia is Alzheimer’s disease (AD). The defining pathology of AD is the build-up of abnormal forms of two proteins in the brain, amyloid and tau. The majority of people with a diagnosis of AD,…

Projet en cours

Voir le projet et les chercheurs